HLB PANAGENE Co., LTD. Logo

HLB PANAGENE Co., LTD.

Specializes in PNA-based molecular diagnostics for oncology and infectious diseases.

046210 | KO

Overview

Corporate Details

ISIN(s):
KR7046210001
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 54, 대전광역시

Description

HLB PANAGENE is a molecular diagnostics company specializing in proprietary Peptide Nucleic Acid (PNA) technology. The company develops, manufactures, and supplies a range of in vitro diagnostic (IVD) products for personalized medicine, with a focus on oncology and infectious diseases. Its portfolio includes diagnostic solutions for various cancers, such as lung, colorectal, and thyroid, by detecting key genetic mutations. The company also offers real-time PCR-based kits for infectious agents like HPV and STIs. Leveraging its PNA platform for high accuracy and rapid analysis, HLB PANAGENE provides PNA materials and diagnostic kits to a global market. Through its subsidiary, the company is expanding its capabilities into immunodiagnostics and point-of-care testing.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-24 00:00
[기재정정]타법인주식및출자증권취득결정
Korean HTML 23.4 KB
2025-12-16 00:00
주주명부폐쇄기간또는기준일설정
Korean HTML 4.3 KB
2025-08-26 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 121.6 KB
2025-08-26 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.2 KB
2025-08-26 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 101.6 KB
2025-08-20 00:00
주권관련사채권의취득결정
Korean HTML 38.2 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean HTML 1.3 MB
2025-07-18 00:00
[기재정정]사업보고서 (2024.12)
Korean HTML 1.8 MB
2025-07-18 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean HTML 15.2 KB
2025-07-18 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean HTML 14.3 KB
2025-06-05 00:00
전환청구권행사
Korean HTML 11.3 KB
2025-05-19 00:00
주식등의대량보유상황보고서(일반)
Korean HTML 230.1 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean HTML 1.3 MB
2025-05-14 00:00
전환청구권행사
Korean HTML 11.3 KB
2025-04-22 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 24.3 KB

Automate Your Workflow. Get a real-time feed of all HLB PANAGENE Co., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB PANAGENE Co., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB PANAGENE Co., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Adaptive Biotechnologies Corp Logo
Decodes the adaptive immune system to develop products for diagnosing and treating disease.
United States of America
ADPT
Adeia Inc. Logo
R&D company that licenses IP for the media, entertainment, and semiconductor industries.
United States of America
ADEA
Aditxt, Inc. Logo
Acquires, develops, and deploys health technologies to address major health challenges.
United States of America
ADTX
Advanced Biomed Inc. Logo
Develops microfluidic biochip diagnostic systems for precision oncology.
United States of America
ADVB
AIM ImmunoTech Inc. Logo
Immuno-pharma company developing therapeutics for oncology, immune, and viral diseases.
United States of America
AIM
Ainos, Inc. Logo
Develops AI-driven diagnostics, immune therapeutics, and telehealth POCT devices.
United States of America
AIMD
Akero Therapeutics, Inc. Logo
Clinical-stage company developing treatments for serious metabolic diseases like MASH.
United States of America
AKRO
Aladdin Healthcare Technologies SE Logo
Develops AI-powered tools for drug discovery and diagnostics for age-related conditions.
Germany
NMI
Alaunos Therapeutics, Inc. Logo
Clinical-stage immuno-oncology company developing TCR-T cell therapies for solid tumors.
United States of America
TCRT
Aligos Therapeutics, Inc. Logo
A clinical-stage biopharmaceutical company developing therapeutics for liver and viral diseases.
United States of America
ALGS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.